- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Nitroxoline is an antibiotic used to treat urinary tract infections. It is a synthetic quinolone derivative, and is available in tablet form. It is used to treat bacterial infections of the urinary tract, including cystitis, urethritis, and pyelonephritis. Nitroxoline is also used to treat other infections, such as respiratory tract infections, skin and soft tissue infections, and bone and joint infections. It is generally well tolerated, with few side effects.
Nitroxoline is available in many countries, including the United States, Canada, Europe, and Australia. It is available as a generic drug, and is also sold under the brand names Uroxin and Uroxatral.
Nitroxoline is an important antibiotic in the treatment of urinary tract infections, and is widely used in clinical practice. It is an effective and safe treatment option for many patients.
Companies in the Nitroxoline market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and AstraZeneca. Show Less Read more